15 days ago
GILD
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Bottom 6%
#4729 out of 4995 analysts
Average Return
-1.26%
Win Rate
45%119 out of 267
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-11 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-09 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-22 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-09 - 2024-03-08 | Buy |
Ambrx Biopharma IncAMAM | +210.77% | $9.01 | $28.00 | 2023-11-13 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
9 months ago
APLT
a year ago
MNMD
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aardvark Therapeutics IncAARD | 4 | Buy | $19.00 | +94.47% | Maintains | 9 days ago |
Xenon Pharmaceuticals IncXENE | 15 | Buy | $55.00 | +41.61% | Maintains | 11 days ago |
Ptc Therapeutics IncPTCT | 17 | Buy | $63.00 | +24.58% | Maintains | 15 days ago |
Gilead Sciences IncGILD | 30 | Hold | $98.00 | -14.61% | Maintains | 15 days ago |
89bio IncETNB | 14 | Hold | $11.00 | +16.65% | Maintains | 15 days ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $40.00 | +55.40% | Maintains | 16 days ago |
Vertex Pharmaceuticals IncVRTX | 54 | Hold | $405.00 | +2.50% | Maintains | 18 days ago |
Prothena Corp Public Ltd CoPRTA | 11 | Hold | $10.00 | +14.03% | Maintains | 18 days ago |
Regeneron Pharmaceuticals IncREGN | 33 | Hold | $695.00 | +17.90% | Maintains | 19 days ago |
Biogen IncBIIB | 37 | Buy | $219.00 | +57.20% | Maintains | 22 days ago |
Neurocrine Biosciences IncNBIX | 20 | Buy | $144.00 | +6.33% | Maintains | 23 days ago |
Incyte CorpINCY | 21 | Hold | $72.00 | -15.33% | Maintains | 24 days ago |
Sarepta Therapeutics IncSRPT | 31 | Hold | $23.00 | +13.75% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 15 | Buy | $13.00 | +51.87% | Reiterates | 2 months ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $75.00 | +13.00% | Maintains | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $67.00 | +19.88% | Reiterates | 3 months ago |
Contineum Therapeutics IncCTNM | 5 | Buy | $31.00 | +211.87% | Reiterates | 3 months ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | +192.97% | Reiterates | 3 months ago |
Karyopharm Therapeutics IncKPTI | 11 | Buy | $33.00 | +423.81% | Maintains | 3 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 7 | Buy | $58.00 | +492.44% | Maintains | 4 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | +136.22% | Reiterates | 4 months ago |
Gh Research PLCGHRS | 1 | Buy | $31.00 | +137.00% | Initiates Coverage On | 6 months ago |
Pliant Therapeutics IncPLRX | 13 | Hold | $3.00 | +106.90% | Maintains | 6 months ago |
Neumora Therapeutics IncNMRA | 6 | Hold | $4.00 | +146.91% | Reiterates | 6 months ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | +20.66% | Maintains | 7 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | +60.00% | Reiterates | 7 months ago |
Intra Cellular Therapies IncITCI | 17 | Hold | $132.00 | +0.10% | Downgrades | 7 months ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | +18.11% | Downgrades | 7 months ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | +127.01% | Downgrades | 8 months ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | -53.92% | Upgrades | 9 months ago |
Galapagos NvGLPG | 10 | Hold | $30.00 | -6.25% | Maintains | 10 months ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | +81.82% | Maintains | 10 months ago |
Mind Medicine IncMNMD | 9 | Buy | $22.00 | N/A | Reiterates | a year ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 2 years ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 4 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 4 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 5 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 8 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.